Is there an ideal way to initiate antiplatelet therapy with aspirin? A crossover study on healthy volunteers evaluating different dosing schemes with whole blood aggregometry

Por Meves, Saskia H, Neubauer, Horst, Overbeck, Ursula, Endres, Heinz G
Publicado em 2011

Ventricular tachycardia during basilar-type migraine attack

Por Pitarokoili, Kalliopi, Dahlhaus, Stefanie, Hellwig, Kerstin, Boehm, Susanne, Neubauer, Horst, Gold, Ralf, Krogias, Christos
Publicado em 2013

The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile

Por Epplen Jörg T, Mügge Andreas, Neubauer Horst, Hanefeld Christoph, Bulut Daniel, Börgel Jan, Holland-Letz Tim, Spiecker Martin
Publicado em 2008-12-01

The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile

Por Börgel, Jan, Bulut, Daniel, Hanefeld, Christoph, Neubauer, Horst, Mügge, Andreas, Epplen, Jörg T, Holland-Letz, Tim, Spiecker, Martin
Publicado em 2008

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

Por Neubauer, Horst, Kaiser, Andreas FC, Endres, Heinz G, Krüger, Jan C, Engelhardt, Andreas, Lask, Sebastian, Pepinghege, Fenena, Kusber, Andreas, Mügge, Andreas
Publicado em 2011